Table 3. Predictive values for advanced liver fibrosis in patients infected with HCV.
PPV | NPV | Sensitivity | Specificity | Accuracy | |
---|---|---|---|---|---|
Serum miR-122 (> 16-fold) (n = 108) | 25% | 65% | 14% | 79% | 57% |
Serum WFA(+)-M2BP (> 2 C.O.I.) (n = 108) | 57% | 83% | 69% | 74% | 72% |
Serum miR-122 (> 16-fold) or serum WFA(+)-M2BP (> 2 C.O.I.) (n = 108) | 49% | 82% | 72% | 63% | 66% |
Serum miR-122 (> 16-fold) and serum WFA(+)-M2BP (> 2 C.O.I.) (n = 108) | 36% | 67% | 11% | 90% | 64% |
PPV, positive predictive value; NPV, negative predictive value